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Crystals have been obtained of the Enterobacter cloacae 908R
-lactamase and two point mutants by the vapour-diffusion method
using similar conditions [pH 9.0, polyethylene glycol (Mr = 6000) as
precipitant]. The three crystal forms belong to the orthorhombic
space group P21212, with roughly the same unit-cell parameters; i.e.
for the wild-type crystals a = 46.46, b = 82.96, c = 95.31 AÊ . In the best
cases, the crystals diffract to about 2.1 AÊ resolution on a rotating-
anode X-ray source at room temperature. Co-crystallization experi-
ments of poor substrates with the wild-type protein and the active-
site serine mutant (S64C) are planned and should lead to a better
understanding of the catalytic mechanism of class C -lactamases.
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1. Introduction
-Lactamases catalyze the hydrolysis of the
lactam bond of -lactam antibiotics, inacti-
vating these compounds and thus protecting
the bacteria that express them. These enzymes
have been grouped into four classes (active-
site serine -lactamase classes A, B and C, and
Zn2+ metallo -lactamase class B) on the basis
of their structures, substrate preferences and
inhibition pattern (Bush et al., 1995). In many
cases, resistance to -lactam antibiotics arises
from a high level of expression of the plasmid-
based TEM class A -lactamases (penicilli-
nases) or of the chromosomally encoded
AmpC class C -lactamases (cephalospor-
inases) (Frere, 1995).
The three-dimensional structure of the
chromosomal cephalosporinases is well known
but their mechanism is still a matter of debate.
The ®rst crystal structure reported was that of
the Citrobacter freundii enzyme in complex
with aztreonam (2.5 AÊ ) (Oefner et al., 1990).
The authors suggested a catalytic role for a
series of amino acids, including Ser64, Lys67,
Tyr150 and Lys315. Three-dimensional struc-
tures of the E. cloacae P99 enzyme (PDB code
2blt) and its complex formed on reaction with a
phosphonate monoester inhibitor (PDB entry
1bls) were then determined (Lobkovsky et al.,
1993, 1994). More recently, the structure of the
AmpC -lactamase from Escherichia coli alone
(PDB code 2bls), in complex with the
transition-state analogue m-aminophenyl-
boronic acid (PDB code 3bls) and with the
inhibitor benzo(b)thiophene-2-boronic acid
(PDB code 1c3b) were obtained at 2.0, 2.3 and
2.25 AÊ resolution, respectively (Usher et al.,
1998; Powers et al., 1999). Finally, Crichlow et
al. (1999) have studied the structure of the
extended-spectrum class C -lactamase of
E. cloacae GC1 at 1.8 AÊ resolution.
As part of our interest in those enzymes,
class C -lactamase from E. cloacae 908R has
been expressed, puri®ed and crystallized. Two
single mutants (S64C and S84C) of the protein
were also produced, puri®ed and crystallized.
This work is the ®rst step towards the structural
analysis of complexes (transition-state analo-
gues, substrates) with this class C -lactamase.
In addition to their being of interest for
mechanistical studies, structures of complexes
between class C -lactamases and synthetic
compounds may also provide a rational basis
for the design of original antibiotics (Weston et
al., 1998; Heinze-Krauss et al., 1998).
2. Material and methods
2.1. Strains, plasmids and mutagenesis
E. cloacae strain Q908R was a gift from Dr
W. Zimmermann (Ciba-Geigy, Basel, Switzer-
land). The strain E. coli SNO302, an ampDÿ
derivative of SNO3 (Lindberg & Normark,
1987), was used in the cloning of the E. cloacae
Q908R ampC gene. The plasmids used were
derivatives of pBR322 constructed by standard
recombinant DNA techniques (Sambrook et
al., 1989). The mutagenesis procedure for the
substitution of residues Ser84 and active-site
Ser64 by cysteine residues was described by
Dubus et al. (1993).
2.2. Enzyme production and purification
Bacteria were grown for 16 h at 310 K in
Terri®c Broth medium supplemented with
Acta Cryst. (2001). D57, 162±164 Wouters et al.  Class C -lactamase 163
crystallization papers
10 mg lÿ1 tetracycline. The cells were
pelleted by centrifugation (4000g, 20 min),
suspended in 10 mM sodium phosphate pH
7.0 containing 1%(v/v) phenylethyl alcohol
and 5 mM EDTA and submitted to three
freeze±thaw cycles to permeabilize the outer
membrane. The cells were sedimented at
15 000g for 20 min and the supernatant was
deposited on a CM-Sepharose column
previously equilibrated in 10 mM sodium
phosphate pH 7.0. The enzyme was eluted
with a linear NaCl gradient (0±0.25 M) in the
same buffer. For both cysteine mutants,
2 mM dithiothreitol was added to all buffers
except that used for elution from the CM-
Sepharose column. After the CM-Sepharose
step, the preparations appeared to be at
least 95% pure by SDS±PAGE (Jacobs et al.,
1992; Dubus et al., 1993; Monnaie et al.,
1994).
2.3. Proteins analysis and enzymatic
activities
Routinely, protein concentrations were
estimated by measuring the absorbance at
280 nm. For pure -lactamase, a molar
absorption of 83 600 Mÿ1 cmÿ1 was calcu-
lated from the content of tryptophan and
tyrosine residues (Cantor & Schimmel,
1980).
-Lactamase activity was determined by
measuring the variation of absorbance upon
hydrolysis of the substrate on a Uvikon 860
spectrophotometer interfaced with micro-
computers. Substrate hydrolysis was
followed at 482 nm for nitroce®n, at 260 nm
for other cephalosporins and at 235 nm for
penicillins at 310 K.
The -lactamase activity of the active-site
serine S64C mutant totally disappeared
upon addition of an excess of 4,40-dipyridyl
disul®de, with a concomitant increase in
absorbance at 324 nm,
which is characteristic of
the reaction of thiols
(Grasseti & Murray, 1967).
A detailed kinetic study
has been performed by





substrates, with kcat values
ranging from 72 to 3000 sÿ1.
Cefuroxime, cefotaxime
and cefoxitin exhibit low
kcat values (0.01±0.08 s
ÿ1)
with low Km values,
suggesting a rate-limiting
deacylation. Imipenem and
aztreonam are even poorer substrates and
behave as transient inactivators.
The S84C mutation has no effect on the
substrate pro®le of the enzyme. The active-
site S64C mutant exhibits drastically
reduced kcat/Km values on all tested
substrates. However, the kcat/Km decrease
did not depend on variations of the same
steady-state parameters in all cases. In most
cases, the mutation transforms the catalytic
properties of the enzyme, replacing a rate-
limiting deacylation by a rate-limiting
acylation. Thus, one could not visualize the
accumulation of acyl-enzyme. The only
exception is cefoxitin, for which accumula-
tion of the acyl-enzyme intermediate is still
observed (Dubus et al., 1993)
Enzyme stability has been studied. The
half-life of the WT enzyme is 18 min at
333 K, whereas the S64C enzyme is slightly
more stable (100 min at 333 K). Tests
performed with nitroce®n at pH 4.5 and
cephaloridine at pH 9.0 showed that the
enzymes were stable over the entire pH
range.
2.4. Crystallization
Crystallization experiments were carried
out at room temperature using the hanging-
drop vapour-diffusion method. The concen-
trations of the puri®ed proteins were
adjusted to 10 mg mlÿ1 in 10 mM HEPES
pH 8.2, 5 mM EDTA, 2 mM DTT buffer for
the S64C and S84C mutants and in 10 mM
Tris±HCl pH 7.5 buffer for the wild-type
protein. Drops were prepared by mixing 3 ml
of protein solution with 3 ml of reservoir
solution and were allowed to equilibrate
against 500 ml of reservoir solution. Crys-
tallization conditions were ®rst investigated
using the sparse-matrix sampling kit
(Hampton Research) and than ®ne-tuned.
Seeding and cross-seeding techniques were
further used to produce large quantities of
crystals.
2.5. Data collection
Selected crystals were mounted in thin-
walled glass capillaries which were sealed
with wax after ®lling both ends with reser-
voir solution. X-ray experiments were
carried out at 293 K using a Siemens X1000
area detector. The X-ray source was
graphite-monochromated Cu K radiation
produced by a Rigaku RU-200 rotating-
anode generator operating at 40 kV and
80 mA with a 0.3 mm ®ne-focus cathode.
The detector was at a distance of 130 mm
with a 2 angle of 22. The data-collection
step size was 0.2 between frames with a
count time of 70 s per frame. Indexing,
integration and scaling of data sets were
carried out using the XENGEN 2.0 package
(Howard et al., 1987). The space group was
determined by examining the intensity
distribution of the X-ray data.
3. Results and discussion
Using the sparse-matrix sampling kit, crys-
talline precipitates and irregular small crys-
tals were obtained when polyethylene glycol
was used as precipitating agent. Attempts to
improve crystal quality were made by using
polyethylene glycols of different molecular
weights and varying the pH of the reservoir
solution. Crystals of both the native enzyme
and the S84C mutant were obtained inde-
pendently. The best results were obtained
with 0.1 M bicine buffer at pH 9.0 and 30%
polyethylene glycol (Mr = 6000) using
seeding techniques. Under these conditions,
well shaped crystals grew to typical dimen-
sions of 0.3  0.3  0.15 mm at room
temperature within a week. The crystal-
lization of the S64C mutant was initiated
under the same conditions by using small
crystals of the wild-type protein as micro-
seeds. Microcrystals obtained from this
cross-seeding were further used to repeat
the experiment in order to dilute out the
effect of heterogeneous seeds.
These crystals diffracted to 2.1 AÊ and
were stable in the X-ray beam. Crystallo-
graphic data of wild-type and both S64C and
S84C mutants of class C -lactamase from
E. cloacae 908R are summarized in Table 1.
The crystals belong to the orthorhombic
space group P21212. The presence of one
monomeric molecule in the asymmetric unit
gives a crystal packing parameter (VM) of
2.35 AÊ 3 Daÿ1 and a solvent content of
47.7%. These values are within the
Table 1
Crystallographic data for the wild-type and two mutant enzymes.
Values in parentheses refer to the highest resolution shell.
Crystal form Wild-type S84C S64C
Space group P21212 P21212 P21212
Unit-cell parameters (AÊ )
a 46.54 82.96 46.07
b 83.45 46.46 82.66
c 95.98 95.31 95.71






Total No. of observations 81043 (1360) 45145 (2753) 48799 (1211)
No. of unique re¯ections 24390 (908) 13652 (1196) 14132 (676)
Completeness (%) 81.5 (31.1) 86.8 (46.7) 75.9 (36.5)
I/(I) 7.80 (1.46) 17.48 (2.83) 8.48 (1.24)









i Ii(h), where Ii(h) and hI(h)i are the ith and
mean measurements of the intensity of re¯ection h.
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frequently observed ranges for protein
crystals (Matthews, 1968).
The structure of the S84C mutant has
been solved by molecular replacement using
the program AMoRe (Navaza, 1994) as
implemented in the CCP4 program suite
(Collaborative Computational Project,
Number 4, 1994). The search model used
was the re®ned 2.3 AÊ structure of the
Enterobacter cloacae P99 enzyme (PDB
code 1bls) using data in the resolution range
10±2.5 AÊ . The 361 amino-acid sequence of
the molecular probe differs by only ®ve
mutations. One clear solution for both the
rotation and translation functions was
directly obtained with an R factor and
correlation coef®cient of 0.28 and 0.804,
respectively. The wild-type and S64C mutant
structures were obtained using AMoRe
(Navaza, 1994) from the starting model of
the S84C mutant after introduction of the
point mutations. Re®nement of all three
structures is in progress.
Crystals of the WT and of S84C will be
further used to study complexes with inhi-
bitors. Preliminary tests have been
performed using transition-state analogues
derived from phenylboronic acids. A
dramatic change in the rate-limiting step of
-lactam hydrolysis results from the substi-
tution of the active-site serine residue by a
cysteine (S64C) (Dubus et al., 1993). There-
fore, we intend to use the crystals obtained
for this mutant in studies of the mechanism
of hydrolysis. A series of slow substrates and
inhibitors will be selected on the basis of
their kinetic properties (Galleni et al., 1988)
to generate the corresponding acyl-enzymes
and/or Michaelis complex.
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